Literature DB >> 2678952

Effect of SK&F 86002 on cytokine production by human monocytes.

J C Lee1, L Rebar, J T Laydon.   

Abstract

Human monocytes respond to a variety of stimuli in vitro by producing a number of physiologically important macromolecules including the cytokines. SK&F 86002, a dual inhibitor of the arachidonate metabolism, has been shown to inhibit LPS induced IL-1 production in human monocytes. We examined its effect on the production of other cytokines which are coordinately expressed as a result of LPS stimulation such as tumor necrosis factor alpha (TNF), alpha interferon (IFN-A), interferon beta-2 (IL-6) and granulocyte colony stimulating factor (g-CSF). The IC50 of SK&F 86002 for the TNF production was 5-8 microM, and greater than 20 microM for the other three cytokines. These IC50s were significantly higher than that previously reported for IL-1 production (1-2 microM). Taken together these data indicate that the inhibitory effect of SK&F 86002 on IL-1 production is selective and the production of cytokines in drug treated monocytes can be differentially affected.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2678952     DOI: 10.1007/bf01972796

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  7 in total

1.  SK&F 86002: a structurally novel anti-inflammatory agent that inhibits lipoxygenase- and cyclooxygenase-mediated metabolism of arachidonic acid.

Authors:  D E Griswold; P J Marshall; E F Webb; R Godfrey; J Newton; M J DiMartino; H M Sarau; J G Gleason; G Poste; N Hanna
Journal:  Biochem Pharmacol       Date:  1987-10-15       Impact factor: 5.858

2.  Objective antiviral assay of the interferons by computer assisted data collection and analysis.

Authors:  R L Forti; S S Schuffman; H A Davies; W M Mitchell
Journal:  Methods Enzymol       Date:  1986       Impact factor: 1.600

3.  Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells.

Authors:  J Gauldie; C Richards; D Harnish; P Lansdorp; H Baumann
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

4.  Purification to homogeneity of a human hematopoietic growth factor that stimulates the growth of a murine interleukin 3-dependent cell line.

Authors:  J D Watson; P S Crosier; C J March; P J Conlon; D Y Mochizuki; S Gillis; D L Urdal
Journal:  J Immunol       Date:  1986-08-01       Impact factor: 5.422

5.  A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes.

Authors:  T Espevik; J Nissen-Meyer
Journal:  J Immunol Methods       Date:  1986-12-04       Impact factor: 2.303

6.  Inhibition of monocyte IL-1 production by the anti-inflammatory compound, SK&F 86002.

Authors:  J C Lee; D E Griswold; B Votta; N Hanna
Journal:  Int J Immunopharmacol       Date:  1988

7.  A modified assay for interleukin-1 (IL-1).

Authors:  P L Simon; J T Laydon; J C Lee
Journal:  J Immunol Methods       Date:  1985-11-28       Impact factor: 2.303

  7 in total
  2 in total

1.  Reduced endotoxin-induced production of tumor necrosis factor activity by equine peritoneal macrophages exposed to the dual inhibitor of arachidonic acid metabolism, SK & F 86002.

Authors:  D D Morris; N Crowe; J N Moore
Journal:  Can J Vet Res       Date:  1992-04       Impact factor: 1.310

2.  Effects of pyridinyl imidazole compounds on murine TNF-alpha production.

Authors:  D L Olivera; J T Laydon; L Hillegass; A M Badger; J C Lee
Journal:  Agents Actions       Date:  1993
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.